Glancy prongay & murray llp reminds investors of looming deadline in the class action lawsuit against acelrx pharmaceuticals, inc. (acrx)

Los angeles--(business wire)---- $acrx #classaction--glancy prongay & murray llp (“gpm”) reminds investors of the upcoming august 9, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired acelrx pharmaceuticals, inc. (“acelrx” or the “company”) (nasdaq: acrx) securities between march 17, 2020 and february 12, 2021, inclusive (the “class period”). if you suffered a loss on your acelrx investments or would like to inquire about potentially
ACRX Ratings Summary
ACRX Quant Ranking